Atlas Trials

A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration

Clinical trial NCT03021785 · UNKNOWN

Trial details

NCT number
NCT03021785
Sponsor
Jiangsu T-Mab Biopharma Co.,Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Neovascular Age-Related Macular Degeneration
Start date
2017-10-18
Primary completion
2018-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.